FDA inobvumidza Recarbio kurapa chipatara-chakawanikwa uye ventilator-inosangana nehutachiona pneumonia
IU.S. Chikafu uye Drug Administration (FDA) yakabvumidza Recarbrio (musanganiswa we imipenem, cilastatin uye relebactam) kurapwa kwechipatara-yakawana bhakitiriya pneumonia uye ventilator-inosangana nehutachiona pneumonia (HABP / VABP) mune varwere vane makore gumi nematanhatu kana kupfuura .
Recarbrio yakambobvumidzwa neFDA yekurapa urwere hwetachiona turakiti uye yakaoma intra-abdominal utachiona kurapwa. Iye zvino, FDA iri kuzivisa kuti inogona kunge iri mushonga wehutachiona hwepneumonia.
Recarbrio, inogona kunge iri mushonga unorwisa mabhakitiriya wephipatara unowanikwa muchipatara?
Kuchengetedza uye kushanda kweRecarbrio kwezvakawedzerwa izvi zviratidzo zvakaongororwa mune yakasarudzika yakadzorwa kliniki muyedzo muvanhu vakuru makumi mashanu neshanu vakapihwa muchipatara neHABP / VABP nekuda kweGram-negative mabhakitiriya: 535 varwere vakarapwa neRecarbrio nevarume 266 vane piperacillin-tazobactam.
Pakazara, pakazosvika zuva 28 reongororo, 16% yevarwere vakarapwa neRecarbrio uye 21% yevamwe vaive vafa.
Antibiotic yebhakitiriya pneumonia: kazhinji kwakajairika maitiro ekuchinja
Mhinduro dzakajairika dzinoonekwa muvarwere vanorapwa neRecarbrio inosanganisira yakawedzera aspartate / alanine aminotransferase, anemia, manyoka, hypokalemia uye hyponatraemia.
Recarbrio yakagamuchira Qualified infinha chirwere chechirwere (QIDP) kudzvinyirirwa pasi peFDA Security uye Innovation Act's Kugadzira Antibiotic Incentives Zvino (GAIN), iyo iyo US agency inofunga nezve antibacterials uye antifungals akafunga kurapa zvakakomba kana zvinokanganisa hupenyu. Sechikamu cheiyo QIDP kududzirwa, Recarbrio yakagadzwa Kukoshesa Kuongorora uye kwakabvumidzwa nePrack Track.
Antibiotic yehutachiona pneumonia: VERENGA IYO ZVINYENGA ZVESE
VERENGA ZVIMWE
Pulmonary uye thyroid carcinoma: FDA inobvumira kurapwa neRetevmo
COVID-19 muUS: FDA yakapa mvumo yekukurumidzira yekushandisa Remdesivir kurapa coronavirus varwere
COVID-19, Andrea Bocelli anokunda coronavirus uye anopa hyperimmune plasma